25871773|t|Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Abeta metabolism in apoE4-targeted replacement mice.
25871773|a|BACKGROUND: Human apolipoprotein E (apoE) exists in three major isoforms: apoE2, apoE3 and apoE4. In the brain, apoE is produced mostly by astrocytes and transports cholesterol to neurons via apoE receptors. Among the gene alleles encoding the three isoforms, the APOE4 allele is the strongest genetic risk factor for late-onset Alzheimer's disease (AD), whereas APOE2 is protective. ApoE4 confers a gain of toxic function, a loss of neuroprotective function or a combination of both in AD pathogenesis. Given that therapeutic impacts of modulating apoE expression may be isoform-dependent, we sought to investigate the relationship between overexpressing apoE isoform and apoE-related functions in apoE-targeted replacement (TR) mice. Specifically, apoE isoform expression driven by the astrocyte-specific glial fibrillary acidic protein (GFAP) promoter was built into an adeno-associated virus serotype 8 (AAV8) vector and injected into the ventricles of postnatal day 2 (P2) apoE3-TR or apoE4-TR mice. Upon confirmation of apoE isoform expression, effects on apoE lipidation and the levels of amyloid-beta (Abeta) in the brain were assessed. RESULTS: AAV8-GFAP-apoE isoforms were specifically expressed in astrocytes throughout all brain regions, which led to overall increased apoE levels in the brain. Viral mediated overexpression of apoE4 in the apoE4-TR background increased poorly-lipidated apoE lipoprotein particles and decreased apoE-associated cholesterol in apoE4-TR mice. Conversely, apoE2 overexpression in apoE4-TR mice enhanced apoE lipidation and associated cholesterol. Furthermore, overexpression of apoE4 elevated the levels of endogenous Abeta, whereas apoE2 overexpression trended to lower endogenous Abeta. CONCLUSIONS: Overexpression of apoE isoforms induces differential effects in the apoE4-TR background: apoE4 decreases apoE lipidation and enhances Abeta accumulation, whereas apoE2 has the opposite effects. Our findings suggest that increasing apoE2 in APOE4 carriers is a beneficial strategy to treat AD, whereas increasing apoE4 in APOE4 carriers is likely harmful. We have also established novel methods to express apoE isoforms in mouse brain to study apoE-related pathways in AD and related dementia.
25871773	74	79	apoE2	Gene	348
25871773	85	90	apoE4	Gene	348
25871773	94	98	apoE	Gene	348
25871773	114	119	Abeta	Gene	11820
25871773	134	139	apoE4	Gene	348
25871773	161	165	mice	Species	10090
25871773	179	184	Human	Species	9606
25871773	185	201	apolipoprotein E	Gene	348
25871773	203	207	apoE	Gene	348
25871773	241	246	apoE2	Gene	348
25871773	248	253	apoE3	Gene	348
25871773	258	263	apoE4	Gene	348
25871773	279	283	apoE	Gene	348
25871773	332	343	cholesterol	Chemical	MESH:D002784
25871773	431	436	APOE4	Gene	348
25871773	496	515	Alzheimer's disease	Disease	MESH:D000544
25871773	517	519	AD	Disease	MESH:D000544
25871773	530	535	APOE2	Gene	348
25871773	551	556	ApoE4	Gene	348
25871773	654	656	AD	Disease	MESH:D000544
25871773	716	720	apoE	Gene	348
25871773	823	827	apoE	Gene	348
25871773	840	844	apoE	Gene	348
25871773	866	870	apoE	Gene	348
25871773	897	901	mice	Species	10090
25871773	917	921	apoE	Gene	348
25871773	974	1005	glial fibrillary acidic protein	Gene	14580
25871773	1007	1011	GFAP	Gene	14580
25871773	1145	1150	apoE3	Gene	348
25871773	1157	1162	apoE4	Gene	348
25871773	1166	1170	mice	Species	10090
25871773	1193	1197	apoE	Gene	348
25871773	1229	1233	apoE	Gene	348
25871773	1277	1282	Abeta	Gene	11820
25871773	1326	1330	GFAP	Gene	14580
25871773	1331	1335	apoE	Gene	348
25871773	1448	1452	apoE	Gene	348
25871773	1507	1512	apoE4	Gene	348
25871773	1520	1525	apoE4	Gene	348
25871773	1567	1571	apoE	Gene	348
25871773	1608	1612	apoE	Gene	348
25871773	1624	1635	cholesterol	Chemical	MESH:D002784
25871773	1639	1644	apoE4	Gene	348
25871773	1648	1652	mice	Species	10090
25871773	1666	1671	apoE2	Gene	348
25871773	1690	1695	apoE4	Gene	348
25871773	1699	1703	mice	Species	10090
25871773	1713	1717	apoE	Gene	348
25871773	1744	1755	cholesterol	Chemical	MESH:D002784
25871773	1788	1793	apoE4	Gene	348
25871773	1828	1833	Abeta	Gene	11820
25871773	1843	1848	apoE2	Gene	348
25871773	1892	1897	Abeta	Gene	11820
25871773	1930	1934	apoE	Gene	348
25871773	1980	1985	apoE4	Gene	348
25871773	2001	2006	apoE4	Gene	348
25871773	2017	2021	apoE	Gene	348
25871773	2046	2051	Abeta	Gene	11820
25871773	2074	2079	apoE2	Gene	348
25871773	2143	2148	apoE2	Gene	348
25871773	2152	2157	APOE4	Gene	348
25871773	2201	2203	AD	Disease	MESH:D000544
25871773	2224	2229	apoE4	Gene	348
25871773	2233	2238	APOE4	Gene	348
25871773	2317	2321	apoE	Gene	348
25871773	2334	2339	mouse	Species	10090
25871773	2355	2359	apoE	Gene	348
25871773	2380	2382	AD	Disease	MESH:D000544
25871773	2395	2403	dementia	Disease	MESH:D003704
25871773	Association	14580	348
25871773	Association	MESH:D000544	348
25871773	Association	11820	348
25871773	Association	MESH:D003704	348
25871773	Association	MESH:D002784	348

